Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Seasonal Allergic Rhinitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Luo Zhang, Medical Ph.D) · dr.luozhang@139.com · +86 13910830399

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure

Seasonal Allergic Rhinitis (SAR)

Abroad (travel likely)RecruitingPHASE2

Mississauga, Canada

Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Abroad (travel likely)RecruitingPHASE2

Beijing, China

A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Abroad (travel likely)Recruiting

Beijing, China